HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 299 filers reported holding HAEMONETICS CORP in Q4 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $1,111 | -35.6% | 12,998 | -32.5% | 1.10% | -48.4% |
Q3 2023 | $1,726 | -2.1% | 19,264 | -7.0% | 2.13% | +15.4% |
Q2 2023 | $1,763 | -99.8% | 20,706 | +109.7% | 1.85% | +24.3% |
Q1 2020 | $984,000 | -41.6% | 9,872 | -32.7% | 1.49% | -18.9% |
Q4 2019 | $1,685,000 | +17.2% | 14,665 | +28.6% | 1.83% | +8.7% |
Q3 2019 | $1,438,000 | +32.8% | 11,400 | +26.7% | 1.69% | +50.5% |
Q2 2019 | $1,083,000 | – | 9,000 | – | 1.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bridge City Capital, LLC | 40,541 | $5,114,000 | 2.20% |
Lisanti Capital Growth, LLC | 53,385 | $6,734,000 | 2.20% |
Nitorum Capital, L.P. | 279,510 | $35,257,000 | 2.05% |
CROWN ADVISORS MANAGEMENT, INC. | 20,000 | $2,523,000 | 1.69% |
Millrace Asset Group, Inc. | 11,400 | $1,438,000 | 1.69% |
COOKSON PEIRCE & CO INC | 145,884 | $18,402,000 | 1.61% |
Endurant Capital Management LP | 32,594 | $4,111,000 | 1.48% |
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 111,000 | $14,002,000 | 1.38% |
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 110,065 | $13,884,000 | 1.37% |
EMERALD ADVISERS, LLC | 203,640 | $25,687,000 | 1.20% |